CDSCO approves over 3000 global clinical trial sites, investigators; prepares comprehensive database Farhat Nasim11 Dec 2019 2:41 PM ISTCDSCO is preparing a comprehensive database of sites and investigators involved in the conduct of the clinical trial in different therapeutic...
Subscription of Piramal debentures by Canadian investor approved by CCI Medical Dialogues Bureau11 Dec 2019 12:28 PM ISTThe Competition Commission of India (CCI) in a tweet said it "approves the subscription of CCDs of Piramal Enterprises by CDPQ. Upon conversion, the...
Merck to acquire cancer drug developer ArQule for USD 2.7 billion Farhat Nasim11 Dec 2019 9:30 AM ISTNew Delhi: Merck, known as MSD outside the United States and Canada, and ArQule, Inc. recently announced that the companies have entered into a...
Sanofi closes research in diabetes, cardiovascular diseases; narrows units to spur profit Medical Dialogues Bureau11 Dec 2019 9:15 AM ISTSanofi, which is due to further detail strategic plans to investors on Tuesday in Cambridge, Massachusetts, said it was targeting new cost savings of...
SETBACK: Correvio Pharma heart drug Brinavess fails to win USFDA panel backing Medical Dialogues Bureau11 Dec 2019 9:10 AM ISTThe panel voted 11-2 against approving Correvio Pharma's drug, Brinavess, citing serious safety risks, including low blood pressure and irregular...
Biohaven Pharma Alzheimers treatment Troriluzole to continue late-stage study Medical Dialogues Bureau11 Dec 2019 9:00 AM ISTBiohaven Pharmaceutical's study of its experimental Alzheimer's treatment, Troriluzole is being led by the Alzheimer's Disease Cooperative Study...
Roche secures CE Mark for Accu-Chek SugarView app for diabetes management Farhat Nasim10 Dec 2019 1:07 PM ISTNow officially classified as in-vitro diagnostics (IVD) software, the app will be made widely accessible by Roche first for certain smartphone models...
Dr Reddys unveils generic Deferasirox Tablets in US Farhat Nasim10 Dec 2019 12:53 PM ISTThe two different products launched by Dr Reddy's Labs in the US market are generic versions of Exjade (deferasirox) and Jadenu (deferasirox)...
With Vildagliptin off-patent from today, new doors open for pharma players Farhat Nasim10 Dec 2019 12:47 PM ISTNew Delhi: The expiry of Swiss-drugmaker Novartis's blockbuster anti-diabetic drug Vildagliptin is being a bringer of glad tidings for Indian Pharma...
Sanofi to acquire biotech firm Synthorx for USD 2.5 billion Medical Dialogues Bureau10 Dec 2019 11:15 AM IST"This acquisition ... is aligned with our goal to build our oncology franchise with potentially practice-changing medicines and novel combinations,"...
JnJ CEO declines to appear at US congressional hearing on carcinogen in baby powder Medical Dialogues Bureau10 Dec 2019 9:15 AM ISTJnJ spokesman Ernie Knewitz said that the subcommittee had rejected the company's offers to send a talc testing expert or a JnJ executive in charge of...
Grifols Alzheimers trial shows positive results Medical Dialogues Bureau10 Dec 2019 9:00 AM ISTThe latest results strengthen Grifols' research on plasma protein replacement therapies, the company said.New Delhi: Spain's Grifols said on Friday...
